Latest Research in Cancer, Hypoxia, and Metabolism
36 research papers · 2026 median publication year
Top Research Topics in Cancer, Hypoxia, and Metabolism
- Ferroptosis and cancer prognosis — 4 papers
- Cancer, Hypoxia, and Metabolism — 3 papers
- RNA modifications and cancer — 3 papers
- Immune cells in cancer — 2 papers
- Cancer Cells and Metastasis — 2 papers
- Pancreatic and Hepatic Oncology Research — 2 papers
- MicroRNA in disease regulation — 2 papers
- Hippo pathway signaling and YAP/TAZ — 2 papers
- interferon and immune responses — 1 papers
- Prostate Cancer Treatment and Research — 1 papers
Highest-Cited Papers
- Multi-omics profiling reveals PIK3CA -driven immunometabolic reprogramming in cervical cancer
- Exosomes From Cancer‐Associated Fibroblasts Suppress Ferroptosis and CD8 + T Cell Effector Function in Gastric Cancer via miR ‐4435/ NDUFA10 Axis
- A disulfidptosis- and glycolysis-related gene signature for prognostic stratification and characterization of the tumor microenvironment in lung adenocarcinoma
- TRIM29 promotes hepatocellular carcinoma progression by inducing K48-linked ubiquitination and degradation of DAPK3
- Tumour cells shape their environment to protect them from the immune system
- PSMA1, PSMA5, and PSMB2 serve as prognostic biomarkers and are correlated with tumor-infiltrating leukocytes in HCC
- A succinylation-related machine learning signature reveals prognostic and immune heterogeneity in lung adenocarcinoma
- Deep learning integration of single-cell and spatial transcriptomics reveals a neutrophil-associated mesenchymal niche and a candidate translocon dependency in lung adenocarcinoma
- The role of SLC16A11 in the survival and immune infiltrates of lung adenocarcinoma (LUAD) patients
- Increased expression of mitochondrial enzyme MTHFD2 associated with clinicopathological features and prognosis of oral squamous cell carcinoma
- Beyond Conventional PDOs: Organoids for Tumorigenesis for Gut Cancer Modeling and Fast Clinical Decision
- Biomarker-Driven Strategies for Stromal Reprogramming in Pancreatic Ductal Adenocarcinoma
- UFMylation-Dependent Stabilization of Emerin Suppresses Hepatocellular Carcinoma via β-Catenin
- Integrated multi-omics analysis identifies AKR1B15 and SLC4A10 as prognostic candidate citrullination-related genes associated with metabolic and immune programs in hepatocellular carcinoma
- ALKBH family gene expression associates with metastasis and clinical features in colorectal cancer
- CHRONIC STRESS AND CANCER PROGRESSION: NEUROENDOCRINE–IMMUNE MECHANISMS AND IMPLICATIONS FOR ANTICANCER THERAPY
- Hakai links m6A RNA methylation to immune regulation in colorectal cancer
- MicroRNAs in HCC: regulatory roles and therapeutic potential
- New Studies Showcase Capabilities of Organoids
- Uridine phosphorylase 1 (UPP1): an emerging regulator in Tumorigenesis, immunity, and beyond